Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.52% | 95.93% | -27.33% | 102.23% | -33.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.52% | 95.93% | -27.33% | 102.23% | -33.60% |
| Cost of Revenue | 72.70% | -22.74% | -11.48% | 18.41% | -32.70% |
| Gross Profit | -7.13% | 220.91% | -32.89% | 172.21% | -34.00% |
| SG&A Expenses | -9.38% | -10.79% | -10.94% | 64.24% | -27.84% |
| Depreciation & Amortization | -- | -- | -76.27% | -100.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.46% | -7.95% | -22.68% | 35.71% | -35.57% |
| Operating Income | -4.72% | 65.77% | -3.76% | 70.76% | 39.51% |
| Income Before Tax | -14.96% | 56.16% | 48.62% | 51.49% | 49.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.96% | 56.16% | 48.62% | 51.49% | 49.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.96% | 56.16% | 48.62% | 51.49% | 49.94% |
| EBIT | -4.72% | 65.77% | -3.76% | 70.76% | 39.51% |
| EBITDA | 12.97% | 73.61% | -502.00% | 61.05% | 16.21% |
| EPS Basic | -16.67% | 56.25% | 50.00% | 52.94% | 50.00% |
| Normalized Basic EPS | 0.00% | 60.00% | 66.67% | 50.00% | 50.00% |
| EPS Diluted | -16.67% | 56.25% | 50.00% | 52.94% | 50.00% |
| Normalized Diluted EPS | 0.00% | 60.00% | 66.67% | 50.00% | 50.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |